A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response

por Denker, Sophy, Bittner, Aitomi, Na, Il-Kang, Kase, Julia, Frick, Mareike, Anagnostopoulos, Ioannis, Hummel, Michael, Schmitt, Clemens A
Publicado 2019